Bradley Bernstein

Bradley E. Bernstein is a biologist and Professor of Pathology at the Massachusetts General Hospital and the Broad Institute of MIT and Harvard. He is the Director of the Broad Institute Epigenomics Program.[1] He is also a professor at Harvard Medical School. He is known for contributions to the fields of epigenetics and cancer biology.

Bradley Bernstein
Born1970 (1970)
Scientific career
FieldsEpigenomics, developmental biology and cancer
InstitutionsMassachusetts General Hospital, Broad Institute, Harvard Medical School

Education

Bernstein received his B.S. in physics from Yale University, and his Ph.D. and M.D. from the University of Washington School of Medicine.

Career and research

Early career

Bernstein completed his residency in clinical pathology at Brigham and Women’s Hospital, and his post-doctoral research in Stuart Schreiber’s lab at Harvard Chemistry. Together with Stuart Schreiber and Eric Lander (Broad Institute), Bernstein characterized the epigenetic landscape in pluripotent embryonic stem cells, leading to the first characterization of bivalent chromatin[2].

Research

Bernstein joined the faculty at Massachusetts General Hospital and Harvard Medical School in 2005. In 2009, he and Alex Meissner launched the Epigenomics Program at the Broad Institute.

Research in the Bernstein laboratory focuses on epigenetics and how changes in gene activity, as opposed to gene sequence, guide development and lead to disease. The lab uses high-throughput genomic technologies to study how chromatin controls gene activity in different contexts. Bernstein's major contributions include ChIP-seq technology, now the standard for mapping chromatin and protein-DNA interactions in mammalian cells[3], the characterization of bivalent chromatin[2] that poises developmental genes for alternate fates in development, and the identification of epigenetic defects that cause brain tumors and treatment failures[4][5][6][7]. He also directs epigenome mapping centers for ENCODE and (formerly) the NIH Epigenomics project at the Broad Institute.

Recognition

In 2009, Bernstein received an Early Career Scientist award from the Howard Hughes Medical Institute. In 2015, he was awarded the Paul Marks prize for Cancer Research.[8] In 2016, he received an NIH Pioneer award,[9] and became the Bernard and Mildred Kayden Endowed MGH Research Institute Chair. Bernstein also serves on the editorial board of Science.

gollark: Code to make the reminder system more real time.
gollark: I can't be bothered to write the reminder thingy code, so PRs for that are extremely welcome.
gollark: Thanks!
gollark: Because PRs are welcome.
gollark: What?

References
  1. "Epigenomics". Broadinstitute.org. 6 July 2016. Retrieved 3 October 2017.
  2. Bernstein, Bradley E.; Mikkelsen, Tarjei S.; Xie, Xiaohui; Kamal, Michael; Huebert, Dana J.; Cuff, James; Fry, Ben; Meissner, Alex; Wernig, Marius; Plath, Kathrin; Jaenisch, Rudolf; Wagschal, Alexandre; Feil, Robert; Schreiber, Stuart L.; Lander, Eric S. (2006). "A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells". Cell. Elsevier BV. 125 (2): 315–326. doi:10.1016/j.cell.2006.02.041. ISSN 0092-8674. PMID 16630819.CS1 maint: ref=harv (link)
  3. Mikkelsen, Tarjei S.; Ku, Manching; Jaffe, David B.; Issac, Biju; Lieberman, Erez; Giannoukos, Georgia; Alvarez, Pablo; Brockman, William; Kim, Tae-Kyung; Koche, Richard P.; Lee, William; Mendenhall, Eric; O’Donovan, Aisling; Presser, Aviva; Russ, Carsten; Xie, Xiaohui; Meissner, Alexander; Wernig, Marius; Jaenisch, Rudolf; Nusbaum, Chad; Lander, Eric S.; Bernstein, Bradley E. (2007-07-01). "Genome-wide maps of chromatin state in pluripotent and lineage-committed cells". Nature. Springer Nature. 448 (7153): 553–560. doi:10.1038/nature06008. ISSN 0028-0836. PMC 2921165. PMID 17603471.CS1 maint: ref=harv (link)
  4. Patel, A. P.; Tirosh, I.; Trombetta, J. J.; Shalek, A. K.; Gillespie, S. M.; Wakimoto, H.; Cahill, D. P.; Nahed, B. V.; Curry, W. T.; Martuza, R. L.; Louis, D. N.; Rozenblatt-Rosen, O.; Suva, M. L.; Regev, A.; Bernstein, B. E. (2014-06-12). "Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma". Science. American Association for the Advancement of Science (AAAS). 344 (6190): 1396–1401. doi:10.1126/science.1254257. ISSN 0036-8075. PMC 4123637. PMID 24925914.CS1 maint: ref=harv (link)
  5. Suvà, Mario L.; Rheinbay, Esther; Gillespie, Shawn M.; Patel, Anoop P.; Wakimoto, Hiroaki; Rabkin, Samuel D.; Riggi, Nicolo; Chi, Andrew S.; Cahill, Daniel P.; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Rivera, Miguel N.; Rossetti, Nikki; Kasif, Simon; Beik, Samantha; Kadri, Sabah; Tirosh, Itay; Wortman, Ivo; Shalek, Alex K.; Rozenblatt-Rosen, Orit; Regev, Aviv; Louis, David N.; Bernstein, Bradley E. (2014). "Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells". Cell. Elsevier BV. 157 (3): 580–594. doi:10.1016/j.cell.2014.02.030. ISSN 0092-8674. PMC 4004670. PMID 24726434.CS1 maint: ref=harv (link)
  6. Flavahan, William A.; Drier, Yotam; Liau, Brian B.; Gillespie, Shawn M.; Venteicher, Andrew S.; Stemmer-Rachamimov, Anat O.; Suvà, Mario L.; Bernstein, Bradley E. (2015-12-23). "Insulator dysfunction and oncogene activation in IDH mutant gliomas" (PDF). Nature. Springer Nature. 529 (7584): 110–114. doi:10.1038/nature16490. ISSN 0028-0836. PMC 4831574. PMID 26700815.CS1 maint: ref=harv (link)
  7. Kolata, Gina (2015-06-10). "Brain Cancers Reveal Novel Genetic Disruption in DNA". The New York Times. Retrieved 2017-07-26.CS1 maint: ref=harv (link)
  8. "Paul Marks Prize for Cancer Research - Memorial Sloan Kettering Cancer Center". Mskcc.org. Retrieved 3 October 2017.
  9. generator, metatags. "Project Information - NIH RePORTER - NIH Research Portfolio Online Reporting Tools Expenditures and Results". projectreporter.nih.gov. Retrieved 3 October 2017.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.